Amalgamated Financial’s Regenxbio RGNX Stock Holding History

Amalgamated Financial’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$593K	Buy	+17,854	New	+$496K	﹤0.01%	1443

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's RGNX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Regenxbio (RGNX) in Q1 2022: 17,854 shares worth $593K. The stake represents ﹤0.01% of the portfolio and ranks #1443 among its holdings.

188 funds tracked by Wall St. Rank hold RGNX as of Q1 2022.

Amalgamated Financial held 17,854 shares of Regenxbio worth $593K as of Q1 2022.
Regenxbio was a new Amalgamated Financial position in Q1 2022.
Regenxbio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1443 holding.
188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.